Fair Value Calculator Fair Value Calculator
EN DE

HGM (HGM) Fair Value & Analysis

Technology · Market cap ₹665M

H HGM HGM · NSE
Price₹52.78
Fair Value₹39.52
Upside-25.1%
Quality47/100
Watch HGM for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹20.03 – ₹59.24

Fair value as of: Jul 3, 2026

From 3 valuation models · updated today

Share price −14.4% over the past month.

Price vs Fair Value (12 months)

₹81.55 ₹44.88 Fair Value ₹39.52 Jun 2025 Jul 2026

12‑month range ₹44.88 – ₹81.55 · fair‑value band ₹20.03 – ₹59.24 · the ₹52.78 price screens above the ₹39.52 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HGM (HGM) currently trades at ₹52.78, while our model-based Fair Value estimate is ₹39.52 — implying the stock looks roughly 25.1% overvalued today. We read business quality at 47/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, HGM generated revenue of ₹595M at a net margin of -5.1%. Revenue grew 129.8% year over year. It earns a return on equity of -13.7%. Net debt stands at ₹172M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹595M
Revenue growth (YoY) +130%
Net margin -5.1%
Return on equity -13.7%
Free cash flow −₹57.4M FY2026
Operating margin -10.7%
More key figures
EPS (TTM) ₹-2.42
Net debt ₹172M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HGM reported revenue of ₹595M in FY2026 versus ₹121M in FY2022, a compound +49.0%/yr. Reported net income was −₹30.5M in FY2026.

Revenue +49.0%/yr
FY22 ₹121M
FY23 ₹161M
FY24 ₹225M
FY25 ₹225M
FY26 ₹595M
Net income
FY22 ₹45.7M
FY23 ₹26.9M
FY24 ₹42.2M
FY25 ₹42.2M
FY26 −₹30.5M

Is HGM fairly valued? → Check now

Similar stocks

6 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
International Business Machines Corporation IBM $252.22 $147.06 -42%
Accenture plc ACN $170.50 $228.49 +34%
Tata Consultancy Services Limited TCS ₹2,199 ₹1,863 -15%
Infosys Limited INFY ₹1,065 ₹15.23 -99%
HCL Technologies Limited HCLTECH ₹1,132 ₹1,230 +9%
Fiserv, Inc FISV 930.00 MXN 1,179 MXN +27%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is HGM (HGM) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹39.52 versus a price of ₹52.78 — about −25% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HGM?
Our model-based fair value for HGM is ₹39.52 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹52.78.
What is the quality score of HGM?
HGM has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of HGM (HGM)?
HGM reported trailing-twelve-month revenue of about ₹595M (latest available figure, as of Jul 3, 2026).
What is the net profit margin of HGM?
The net profit margin of HGM is about -5.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.